HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Postischemic renal injury due to oxygen radicals.

Abstract
Ischemia-reperfusion injury occurs in many organs and is the underlying cause of many disease processes, including myocardial infarction, stroke, and acute renal failure, which in total are responsible for the majority of deaths seen in developed countries. Most of the injury seen with this process is associated with the reperfusion phase in which the blood flow to the ischemic tissues is reinstituted. This reperfusion phase is associated with the formation of reactive oxygen species (ROS) in the tissues, and the sources of these oxidants are both the neutrophil as well as parenchymal cells such as endothelium. In the kidney as well as other organs, antioxidant therapy is protective, suggesting an important role for these agents. However, there is emerging evidence that ROS are not solely responsible for the reperfusion injury. In many of the kidney models of ischemia-reperfusion, antioxidants are only partially effective in ameliorating the functional and morphologic alterations. Furthermore, in vitro, ROS do not appear to be primarily involved in the killing of renal tubular epithelial cells, which is the morphologic hallmark of acute renal failure. Thus, reperfusion injury, like other types of tissue injury, appears to be mediated by more than one class of inflammatory mediator.
AuthorsK J Johnson, J M Weinberg
JournalCurrent opinion in nephrology and hypertension (Curr Opin Nephrol Hypertens) Vol. 2 Issue 4 Pg. 625-35 (Jul 1993) ISSN: 1062-4821 [Print] England
PMID7859026 (Publication Type: Journal Article, Review)
Chemical References
  • Reactive Oxygen Species
Topics
  • Animals
  • Humans
  • Kidney Diseases (metabolism, physiopathology)
  • Reactive Oxygen Species
  • Reperfusion Injury (metabolism, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: